Literature DB >> 21625332

Stability of Sodium Nitroprusside and Sodium Thiosulfate 1:10 Intravenous Admixture.

Lucas T Schulz1, Edmund J Elder, Karen J Jones, Ashwanth Vijayan, Benjamin D Johnson, Joshua E Medow, Lee Vermeulen.   

Abstract

PURPOSE: Thiosulfate has been shown to reduce the risk of cyanide toxicity during nitroprusside administration. Admixtures containing both agents may provide a safe and effective alternative to more expensive agents used to reduce blood pressure in the critically ill patient. This study determined the physical and chemical stability of a 1:10 nitroprusside:thiosulfate admixture, stored up to 48 hours. The economic consequences of a shift toward using thiosulfate and nitroprusside, and away from higher cost alternatives, are considered.
METHODS: Seven samples of 50 mg nitroprusside and 500 mg thiosulfate were prepared and stored away from light, at room temperature, and in a refrigerator prepared in D5W and NS. Each sample was analyzed via a novel high-performance liquid chromatographic (HPLC) method at time 0, 8, 24, and 48 hours. The method was tested and passed specifications for linearity, reproducibility, and accuracy. A visual inspection by 9 licensed pharmacists was used to demonstrate physical stability. A cost evaluation comparing nitroprusside and thiosulfate to alternative agents was completed.
RESULTS: The concentration of both nitroprusside and thiosulfate remain greater than 95% of the initial concentration through 48 hours. Physical compatibility was confirmed in all samples tested through 72 hours.
CONCLUSION: The combination of nitroprusside and thiosulfate is chemically and physically stable as a single compounded dose for up to 48 hours when stored at room temperature and protected from light. The admixture represents an inexpensive option to other higher cost alternatives such as nicardipine or clevidipine.

Entities:  

Year:  2010        PMID: 21625332      PMCID: PMC3102563          DOI: 10.1310/hpj4510-779

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  5 in total

1.  Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting.

Authors:  Jeffrey E Thomas; Gerri McGinnis
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

2.  Comparison of visual and turbidimetric methods for determining short-term compatibility of intravenous critical-care drugs.

Authors:  J F Dasta; K N Hale; G L Stauffer; M M Tschampel
Journal:  Am J Hosp Pharm       Date:  1988-11

3.  Cyanide toxicity of sodium nitroprusside in therapeutic use with and without sodium thiosulphate.

Authors:  V Schulz; R Gross; T Pasch; J Busse; G Loeschcke
Journal:  Klin Wochenschr       Date:  1982-11-15

Review 4.  Sodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosulfate prophylaxis.

Authors:  V A Hall; J M Guest
Journal:  Am J Crit Care       Date:  1992-09       Impact factor: 2.228

5.  Prospective randomized comparison of safety and efficacy of nicardipine and nitroprusside drip for control of hypertension in the neurosurgical intensive care unit.

Authors:  Ben Z Roitberg; Julian Hardman; Klaudia Urbaniak; Amina Merchant; Erwin Z Mangubat; Ali Alaraj; Nada Mlinarevich; Karriem S Watson; Sean Ruland
Journal:  Neurosurgery       Date:  2008-07       Impact factor: 4.654

  5 in total
  1 in total

1.  Clevidipine for perioperative blood pressure control in infants and children.

Authors:  Joseph D Tobias; David B Tulman; Sergio D Bergese
Journal:  Pharmaceuticals (Basel)       Date:  2013-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.